In the BioHarmony Drug Report Database

"Preview" Icon

Ephedrine

Akovaz, Corphedra, Emerphed, Ephedrine Sulfate (ephedrine) is a small molecule pharmaceutical. Ephedrine was first approved as Akovaz on 2016-04-29. It is used to treat asthma, bronchial spasm, orthostatic hypotension, and rhinitis in the USA. The pharmaceutical is active against beta-2 adrenergic receptor. Primatene’s patents are valid until 2040-05-16 (FDA).

 

Trade Name

 

Akovaz, Corphedra, Emerphed, Ephedrine Sulfate
 

Common Name

 

ephedrine
 

ChEMBL ID

 

CHEMBL211456
 

Indication

 

asthma, bronchial spasm, orthostatic hypotension, rhinitis
 

Drug Class

 

Sympathomimetics

Image (chem structure or protein)

Ephedrine structure rendering